JW Holdings Corp
096760
Company Profile
Business description
JW Holdings Corp is a healthcare solutions provider. It is a drug manufacturer based in Korea and its key focus areas are raw material, completion medicine, medical supplies and medical appliances. The company's array of products comprises of antimicrobials, antifungals, anticancer and gastrointestinal agents. It licenses and markets in its home country and in regions such as United States, Japan, Germany, and China.
Contact
698 Sindaebang 1-dong
Dongjak-gu
Seoul156-010
KORT: +82 28406777
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
134
Stocks News & Analysis
stocks
What to expect from the January Fed meeting
Central bankers are likely to hold interest rates steady, but Wall Street is focused on life after Powell.
stocks
Fortescue costs outpace increasing volume
Higher diesel prices and foreign exchange hit unit cash costs.
stocks
A top global stock to buy after a big change in its forecast
Undervalued by 24%, this wide-moat stock is a buy now.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,260.00 | 1.50 | 0.02% |
| CAC 40 | 8,131.15 | 11.90 | -0.15% |
| DAX 40 | 24,933.08 | 32.37 | 0.13% |
| Dow JONES (US) | 49,412.40 | 313.69 | 0.64% |
| FTSE 100 | 10,148.85 | 5.41 | 0.05% |
| HKSE | 27,068.97 | 303.45 | 1.13% |
| NASDAQ | 23,601.36 | 100.11 | 0.43% |
| Nikkei 225 | 53,017.71 | 132.46 | 0.25% |
| NZX 50 Index | 13,443.49 | 17.25 | -0.13% |
| S&P 500 | 6,950.23 | 34.62 | 0.50% |
| S&P/ASX 200 | 8,935.20 | 8.50 | 0.10% |
| SSE Composite Index | 4,131.89 | 0.72 | -0.02% |